Results 231 to 240 of about 16,135,907 (266)

Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini, Giulia Tammam, Andra Ezaru, Manuela Gambella, Benoît Sanson, Luisa Villa, Michele Cavalli, Mihai‐Bogdan Ioncea, Angela Puma, Sabrina Sacconi   +9 more
wiley   +1 more source

Evidence-based clinical practice guidelines for diagnosis and medical management of acute colonic diverticulitis developed by the Korean Association for the Study of Intestinal Diseases (KASID). [PDF]

Intest Res
Lee JG, Park YE, Chang JY, Song HJ, Kim DH, Yang YJ, Kim BC, You MW, Kim K, Kim KW, Kim Y, Kim SE, Myung SJ, Clinical Practice Guideline Taskforce of the Korean Association for the Study of Intestinal Diseases.   +13 more
europepmc   +1 more source

Early Clinical and Cerebrospinal Fluid Predictors of 1‐Year Recurrence in Autoimmune GFAP Astrocytopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP‐A) is an inflammatory central nervous system disorder with variable outcomes. Relapse occurs in a subset of patients, but early predictors remain unclear. We aimed to identify admission‐available features associated with 1‐year recurrence and develop an interpretable ...
Qingting Hong, Yuping Xiao, Yuhan Wu, Ziyuan Huang, Weishan Liang, Li Xiao, Yaqing Shu, Tingting Lu, Yanyu Chang, Wei Qiu, Yuge Wang   +10 more
wiley   +1 more source

Practical guidelines on medical management of adults with moderate-to-severe inflammatory bowel disease. [PDF]

Saudi J Gastroenterol
Mosli MH, Al-Bawardy B, AlAmeel T, Azzam NA, Bakkari SA, Alharbi OR, Almutairdi A, Meeralam YK, Saadah OI, Almadi MA, Alhazzani W, Alotaibi HF, Alenzi KA, Al-Omari BA, Almudaiheem HY, Al-Jedai AH.   +15 more
europepmc   +1 more source

Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐NMDA Receptor Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley   +1 more source

Durability of Drug-Eluting Balloon-Mounted Stents in Symptomatic ICAD: A Propensity-Matched Landmark Analysis of RO-ZES Versus Wingspan or Medical Management Beyond 24 Months. [PDF]

Stroke Vasc Interv Neurol
Shoraka O, Haim O, Miller S, Roy JM, Jaikumar V, Musmar B, Tanweer O, Burkhardt JK, Jabbour PM, Siddiqui AH, Siddiq F, Hassan AE, Grandhi R.   +12 more
europepmc   +1 more source

Role of Point-of-Care Ultrasound in Inpatient Perioperative Medical Management: A Systematic Review. [PDF]

J Clin Med
Jarsania DM, Breunig MJ, Kolar GJ, Issa M, Kingsley R, Bhuiyan MN, Chelf CJ, Kirchoff RW.   +7 more
europepmc   +1 more source

Chronic rhinosinusitis: a qualitative study of patient and clinician experiences of the MACRO randomised controlled trial of surgical versus medical management. [PDF]

BMJ Open
Vennik J, McDermott C, Williams SJ, Thomas M, Boardman J, Philpott CM, Little P, Schilder A, Hopkins C.   +8 more
europepmc   +1 more source

Five-year prospective outcomes of medical management and microvascular decompression in trigeminal neuralgia. [PDF]

J Neurol
Worm J, Heinskou TB, Rochat P, Springborg JB, Smilkov EA, Bendtsen L, Schytz HW, Maarbjerg S.   +7 more
europepmc   +1 more source

Medical Management of Tenosynovial Giant Cell Tumor. [PDF]

Curr Oncol Rep
Palmerini E, Trent JC, Hornicek FJ.
europepmc   +1 more source